TY - JOUR
T1 - Surrogate end points in cardio-thoracic trials
T2 - a call for better reporting and improved interpretation of trial findings
AU - Ciani, Oriana
AU - Manyara, Anthony Muchai
AU - Taylor, Rod S
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Evidence to inform regulatory, funding and clinical decisions about health interventions should come from well-conducted clinical trials. Despite the challenges associated to their design, conduct and generalizability, randomized controlled trials (RCTs) are typically considered the studies providing the least biased estimates of treatment effects
AB - Evidence to inform regulatory, funding and clinical decisions about health interventions should come from well-conducted clinical trials. Despite the challenges associated to their design, conduct and generalizability, randomized controlled trials (RCTs) are typically considered the studies providing the least biased estimates of treatment effects
U2 - 10.1093/ejcts/ezac449
DO - 10.1093/ejcts/ezac449
M3 - Article (Academic Journal)
C2 - 36112148
SN - 1010-7940
VL - 62
JO - European Journal of Cardio-Thoracic Surgery
JF - European Journal of Cardio-Thoracic Surgery
IS - 4
M1 - ezac449
ER -